6505--Mesalamine 1200mg Tablet
SOL #: 36E79726R0025Pre-Solicitation
Overview
Buyer
Veterans Affairs
Veterans Affairs, Department Of
NAC PHARMACEUTICALS (36E797)
HINES, IL, 60141, United States
Place of Performance
Place of performance not available
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Apr 23, 2026
2
Response Deadline
Jun 9, 2026, 7:30 PM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The VA National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP) 36E79726R0025 for an uninterrupted source of supply for Mesalamine 1200MG (1.2GM) Tablets Enteric Coated (EC) Delayed Release (DR). This procurement will serve the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The tentative closing date for proposals is June 9, 2026.
Scope of Work
The requirement is for Mesalamine 1200MG (1.2GM) Tablets EC DR, packaged as 120 tablets per bottle. Key specifications include:
- Labeling: Offerors must provide the exact drug name and a unique NDC number. The successful offeror's label with its unique NDC must be the only label on the product, with VA labels adhering on top.
- Bottle Specifications: Unit of use packaging (120 count bottles) must feature a safety-cap (deshellable/convertible) and a bottle with a minimum 120cc volume. The bottle must be cylindrical, have a minimum 5.75" circumference, and accommodate a 5.25" x 2" label with an additional 0.5" space for barcode/expiration/lot number.
- Estimated Annual Usage: 107,364 bottles.
Contract & Timeline
- Contract Type: One contract will be awarded.
- Period of Performance: One base year plus four pre-priced one-year option periods.
- Distribution: Through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
- Solicitation Issuance: Expected on or about May 25, 2026.
- Response Date: Tentative closing date of June 9, 2026, 2:30 PM Central Time, Chicago, USA.
- Format: Electronically issued in commercial item format in accordance with FAR Part 12.
Eligibility / Set-Aside
- Procurement Type: Unrestricted.
Additional Notes
- NAICS Code: 325412.
- Contracting Office: Department of Veterans Affairs, OPAL National Acquisition Center, Hines, IL 60141.
- Point of Contact: Youlanda Duggar, Contract Specialist, Youlanda.Duggar@va.gov, 708-786-4943.
- All documents and amendments will be available electronically for download at SAM.gov. Interested offerors should continuously check SAM.gov for updates.
People
Points of Contact
Youlanda DuggarContract SpecialistPRIMARY
Files
Files
Versions
Version 1Viewing
Pre-Solicitation
Posted: Apr 23, 2026